Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market

Growing Prominence of Single Use Technologies and Biologics Market Driving Growth
Share this:
Published: 14 Feb 2017

This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is expected to expand at a compound annual growth rate of 12.1% from 2015 to 2020, driven by the increasing adoption of single use technologies, increased demand due to stringent regulatory scrutiny, CROs evolving as development partners and increasing prominence of biologics leading to need for comprehensive E&L testing programs. With the increasing prominence of single use systems (SUS), the global E&L testing market is expected to experience a robust growth. Emerging markets such as India and China are becoming hubs for contract manufacturing for such services, as these countries are building strong local expertise in analytical laboratory testing. The pharma industry is becoming more aware of the impact of E&L for protection of patients, leading to increased and stringent scrutiny by regulatory agencies. Bio/Pharma companies are increasingly outsourcing these services to reduce the burden on internal staff and also expedite the time to market for drugs.



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..